speb/financial-data huggingface dataset:
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Invested Capital: 146428000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Investing Cash Flow: -580000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: -367000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Issuance Of Capital Stock: 221000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Issuance Of Capital Stock: 103000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Issuance Of Debt: 15666000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Issuance Of Debt: 4483000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Land And Improvements: 204000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Land And Improvements: 204000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Long Term Capital Lease Obligation: 0.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Long Term Capital Lease Obligation: 0.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Long Term Debt: 61984000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Long Term Debt: 61984000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 61984000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 61984000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Long Term Debt Issuance: 15666000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Long Term Debt Issuance: 4971000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Long Term Debt Payments: -18478000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Long Term Debt Payments: -3638000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Machinery Furniture Equipment: 5656000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Machinery Furniture Equipment: 5656000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Net Business Purchase And Sale: 300000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Net Business Purchase And Sale: 0.00
AVGO.TO cash_flow (annual, 2025-10-31) — Net Common Stock Issuance: -6089000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Net Common Stock Issuance: 103000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Net Debt: 48958000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Net Debt: 48958000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Net Income: 23126000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Net Income: 8518000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Net Income Common Stockholders: 23126000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: 8518000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Net Income Continuous Operations: 23126000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: 8518000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Net Income Discontinuous Operations: 0.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Net Income Discontinuous Operations: 0.00
AVGO.TO income_statement (annual, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 23126000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 8518000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 23126000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 8518000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Net Income From Continuing Operations: 23126000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: 8518000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Net Income Including Noncontrolling Interests: 23126000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: 8518000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Net Interest Income: -2863000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Net Interest Income: -414000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Net Investment Purchase And Sale: -349000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Net Investment Purchase And Sale: -235000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Net Issuance Payments Of Debt: -2812000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Net Issuance Payments Of Debt: 845000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Net Long Term Debt Issuance: -2812000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Net Long Term Debt Issuance: 1333000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Net Non Operating Interest Income Expense: -2863000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: -414000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Net Other Financing Charges: -84000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Net Other Financing Charges: -27000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Net Other Investing Changes: 92000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Net Other Investing Changes: 105000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Net PPE: 2530000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Net PPE: 2530000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Net PPE Purchase And Sale: -623000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: -237000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Net Tangible Assets: -48782000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: -48782000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Non Current Deferred Liabilities: 6251000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Liabilities: 6251000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Non Current Deferred Revenue: 3547000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Revenue: 3547000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Non Current Deferred Taxes Liabilities: 2704000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Taxes Liabilities: 2704000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Normalized EBITDA: 35322000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Normalized EBITDA: 10026000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Normalized Income: 23606320000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Normalized Income: 8646770000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Operating Cash Flow: 27537000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: 7703000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Operating Gains Losses: 138000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: 20000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Operating Income: 26075000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Operating Income: 7654000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Operating Revenue: 63887000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Operating Revenue: 18015000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Ordinary Shares Number: 4741000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 4741000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Other Current Assets: 457000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Other Current Assets: 457000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Other Current Borrowings: 3152000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Other Current Borrowings: 3152000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Other Current Liabilities: 663000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Other Current Liabilities: 663000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Other Equity Adjustments: 218000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: 218000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Other Income Expense: -483000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Other Income Expense: -371000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Other Intangible Assets: 32273000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Other Intangible Assets: 32273000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Other Non Cash Items: 438000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: 107000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Other Non Current Assets: 6915000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Other Non Current Assets: 6915000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Other Non Current Liabilities: 1423000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Other Non Current Liabilities: 1423000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Other Non Operating Income Expenses: 125000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Other Non Operating Income Expenses: -208000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Other Receivables: 5005000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Other Receivables: 5005000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Payables: 2481000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Payables: 2481000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Payables And Accrued Expenses: 3101000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 3101000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Pensionand Other Post Retirement Benefit Plans Current: 2129000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Pensionand Other Post Retirement Benefit Plans Current: 2129000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Preferred Stock: 0.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Preferred Stock: 0.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Prepaid Assets: 518000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Prepaid Assets: 518000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Pretax Income: 22729000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Pretax Income: 6869000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Properties: 0.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Properties: 0.00
AVGO.TO cash_flow (annual, 2025-10-31) — Purchase Of Business: 0.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Purchase Of Business: 0.00
AVGO.TO cash_flow (annual, 2025-10-31) — Purchase Of Investment: -597000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Purchase Of Investment: -336000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Purchase Of PPE: -623000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Purchase Of PPE: -237000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Raw Materials: 308000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Raw Materials: 308000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Receivables: 12150000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Receivables: 12150000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Reconciled Cost Of Revenue: 13849000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Reconciled Cost Of Revenue: 4040000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Reconciled Depreciation: 8775000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 2233000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Repayment Of Debt: -18478000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Repayment Of Debt: -3638000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Repurchase Of Capital Stock: -6310000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Repurchase Of Capital Stock: 0.00
AVGO.TO income_statement (annual, 2025-10-31) — Research And Development: 10977000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Research And Development: 2981000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Restructuring And Mergern Acquisition: 591000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Restructuring And Mergern Acquisition: 146000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Retained Earnings: 9761000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Retained Earnings: 9761000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Sale Of Business: 300000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Sale Of Business: 0.00
AVGO.TO cash_flow (annual, 2025-10-31) — Sale Of Investment: 248000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Sale Of Investment: 101000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Selling General And Administration: 4211000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Selling General And Administration: 1107000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Share Issued: 4741000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Share Issued: 4741000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Special Income Charges: -591000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Special Income Charges: -146000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Stock Based Compensation: 7568000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 2195000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Stockholders Equity: 81292000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 81292000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Tangible Book Value: -48782000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: -48782000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Tax Effect Of Unusual Items: -127680000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: -34230000.00
AVGO.TO income_statement (annual, 2025-10-31) — Tax Provision: -397000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Tax Provision: -1649000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Tax Rate For Calcs: 0.21
AVGO.TO income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.21
AVGO.TO balance_sheet (annual, 2025-10-31) — Total Assets: 171092000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Total Assets: 171092000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Total Capitalization: 143276000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 143276000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Total Debt: 65136000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Total Debt: 65136000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Total Equity Gross Minority Interest: 81292000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 81292000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Total Expenses: 37812000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Total Expenses: 10361000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Total Liabilities Net Minority Interest: 89800000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 89800000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Total Non Current Assets: 139519000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 139519000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 71286000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 71286000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Total Operating Income As Reported: 25484000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Total Operating Income As Reported: 7508000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Total Tax Payable: 921000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Total Tax Payable: 921000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Total Unusual Items: -608000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Total Unusual Items: -163000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Total Unusual Items Excluding Goodwill: -608000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Total Unusual Items Excluding Goodwill: -163000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Tradeand Other Payables Non Current: 1628000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Tradeand Other Payables Non Current: 1628000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Work In Process: 1280000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Work In Process: 1280000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Working Capital: 13059000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Working Capital: 13059000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — +Operating Expense: 4491000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — +Total Revenue: 19311000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 2112000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 8460000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 73135000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Amortization: 507000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Amortization Cash Flow: 2003000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Amortization Of Intangibles: 2003000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Amortization Of Intangibles Income Statement: 507000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Basic Average Shares: 26854799424.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Basic EPS: 0.27
AVGO.TO cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 16178000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Capital Expenditure: -250000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Capital Stock: 5000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 14174000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 14174000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Cash Dividends Paid: -3086000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: -10149000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: -115000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: 8260000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Change In Account Payable: 534000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Change In Inventory: -692000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Change In Other Working Capital: -1632000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Change In Payable: 534000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: 534000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Change In Receivables: -1315000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Change In Working Capital: -3105000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Changes In Account Receivables: -1315000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Changes In Cash: -2004000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Common Stock: 5000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Common Stock Dividend Paid: -3086000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 79872000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Common Stock Payments: -7850000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Cost Of Revenue: 6154000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Current Accrued Expenses: 673000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Current Assets: 32062000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Current Debt: 2252000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Current Debt And Capital Lease Obligation: 2252000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Current Deferred Liabilities: 9188000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Current Deferred Revenue: 9188000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 16859000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Deferred Income Tax: -455000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Deferred Tax: -455000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Depreciation: 150000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 2153000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Depreciation Amortization Depletion Income Statement: 507000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 2153000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Depreciation And Amortization In Income Statement: 507000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 27687462474.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Diluted EPS: 0.26
AVGO.TO income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: 7349000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — EBIT: 8996000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — EBITDA: 11149000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — End Cash Position: 14174000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: -10149000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Finished Goods: 842000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Free Cash Flow: 8010000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: 212000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Goodwill: 97801000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Goodwill And Other Intangible Assets: 128103000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Gross Profit: 13157000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Income Tax Paid Supplemental Data: 782000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Interest Expense: 801000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Interest Expense Non Operating: 801000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Interest Paid Supplemental Data: 619000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Interest Payable: 673000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Inventory: 2962000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Invested Capital: 145929000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: -115000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Issuance Of Debt: 4474000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Long Term Debt: 63805000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 63805000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Long Term Debt Issuance: 4474000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Long Term Debt Payments: -3650000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: -7850000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Net Debt: 51883000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Net Income: 7349000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: 7349000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: 7349000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: 7349000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: 7349000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: 7349000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: 7349000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Net Interest Income: -801000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Net Investment Purchase And Sale: 130000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Net Issuance Payments Of Debt: 824000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Net Long Term Debt Issuance: 824000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: -801000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Net Other Financing Charges: -37000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Net Other Investing Changes: 5000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Net PPE: 2599000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: -250000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Net Short Term Debt Issuance: 0.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: -48231000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Liabilities: 5889000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Revenue: 3667000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Liabilities: 2222000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Normalized EBITDA: 11252000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Normalized Income: 7441366931.06
AVGO.TO cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: 8260000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Operating Gains Losses: 55000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Operating Income: 8666000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Operating Revenue: 19311000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 4736000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Other Current Assets: 289000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Other Current Borrowings: 2252000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Other Current Liabilities: 682000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Other Equity Adjustments: 212000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Other Income Expense: 330000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Other Intangible Assets: 30302000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: 87000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Other Non Current Assets: 7139000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Other Non Current Liabilities: 1810000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Other Non Operating Income Expenses: 433000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Other Receivables: 5536000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Payables: 3200000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 3873000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 864000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Preferred Stock: 0.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Prepaid Assets: 641000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Pretax Income: 8195000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Purchase Of Investment: -114000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: -250000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Raw Materials: 576000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Receivables: 13996000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Reconciled Cost Of Revenue: 4508000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 2153000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Repayment Of Debt: -3650000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Repurchase Of Capital Stock: -7850000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Research And Development: 2965000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Restructuring And Mergern Acquisition: 103000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Retained Earnings: 6520000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Sale Of Investment: 244000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Selling General And Administration: 1019000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Share Issued: 4736000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Short Term Debt Issuance: 0.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Special Income Charges: -103000000.00
AVGO.TO cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 2176000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 79872000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: -48231000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: -10633068.94
AVGO.TO income_statement (quarterly, 2026-01-31) — Tax Provision: 846000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.10
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Total Assets: 169903000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 143677000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Total Debt: 66057000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 79872000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Total Expenses: 10645000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 90031000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 137841000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 73172000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: 8563000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Total Tax Payable: 1088000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Total Unusual Items: -103000000.00
AVGO.TO income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: -103000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Tradeand Other Payables Non Current: 1668000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Work In Process: 1544000000.00
AVGO.TO balance_sheet (quarterly, 2026-01-31) — Working Capital: 15203000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — +Operating Expense: 4556000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — +Total Revenue: 22187000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 2337000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 10830000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Additional Paid In Capital: 75312000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Amortization: 506000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Amortization Cash Flow: 2002000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Amortization Of Intangibles: 2002000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Amortization Of Intangibles Income Statement: 506000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Basic Average Shares: 26888785671.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Basic EPS: 0.35
AVGO.TO cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 14174000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -231000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Capital Stock: 5000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 19628000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 19628000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Cash Dividends Paid: -3092000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: -4831000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -208000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: 10493000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Change In Account Payable: 149000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Change In Inventory: -1366000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Change In Other Working Capital: 1015000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Change In Payable: 149000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: 149000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Change In Receivables: -2370000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Change In Working Capital: -2572000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Changes In Account Receivables: -2370000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Changes In Cash: 5454000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Common Stock: 5000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Common Stock Dividend Paid: -3092000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 87691000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Common Stock Payments: -600000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 6772000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Current Accrued Expenses: 656000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Current Assets: 42213000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Current Debt: 2252000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Current Debt And Capital Lease Obligation: 2252000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Current Deferred Liabilities: 10038000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Current Deferred Revenue: 10038000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 18862000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Deferred Income Tax: -603000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Deferred Tax: -603000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Depreciation: 163000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 2165000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Depreciation Amortization Depletion Income Statement: 506000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 2165000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Depreciation And Amortization In Income Statement: 506000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 27619489980.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Diluted EPS: 0.34
AVGO.TO income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: 9310000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — EBIT: 10906000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — EBITDA: 13071000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — End Cash Position: 19628000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: -4831000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Finished Goods: 1858000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Free Cash Flow: 10262000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: 208000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Goodwill: 97801000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Goodwill And Other Intangible Assets: 126134000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Gross Profit: 15415000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Income Tax Paid Supplemental Data: 1099000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Interest Expense: 776000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Interest Expense Non Operating: 776000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Interest Paid Supplemental Data: 695000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Interest Payable: 656000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Inventory: 4328000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Invested Capital: 152598000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: -208000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Issuance Of Debt: 0.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Long Term Debt: 62655000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 62655000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Long Term Debt Issuance: 0.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Long Term Debt Payments: -1250000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: -487000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Net Debt: 45279000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Net Income: 9310000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: 9310000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: 9310000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: 9310000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: 9310000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: 9310000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: 9310000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Net Interest Income: -776000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Net Investment Purchase And Sale: 16000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Net Issuance Payments Of Debt: -1250000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Net Long Term Debt Issuance: -1250000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: -776000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Net Other Financing Charges: -2000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Net Other Investing Changes: 7000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Net PPE: 2788000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: -231000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Net Short Term Debt Issuance: 0.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: -38443000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Liabilities: 5819000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Revenue: 4204000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Taxes Liabilities: 1615000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Normalized EBITDA: 13142000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Normalized Income: 9375252714.71
AVGO.TO cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: 10493000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: 31000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Operating Income: 10859000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Operating Revenue: 22187000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 4758000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Other Current Assets: 369000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Other Current Borrowings: 2252000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Other Current Liabilities: 1228000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Other Equity Adjustments: 208000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Other Income Expense: 47000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Other Intangible Assets: 28333000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Other Non Cash Items: 70000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Other Non Current Assets: 8023000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Other Non Current Liabilities: 2469000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Other Non Operating Income Expenses: 118000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Other Receivables: 5918000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Payables: 3554000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 4210000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Pensionand Other Post Retirement Benefit Plans Current: 1134000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Preferred Stock: 0.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Prepaid Assets: 1140000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Pretax Income: 10130000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Purchase Of Investment: -23000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Purchase Of PPE: -231000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Raw Materials: 669000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Receivables: 16748000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Reconciled Cost Of Revenue: 5113000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 2165000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Repayment Of Debt: -1250000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Repurchase Of Capital Stock: -600000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Research And Development: 2995000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Restructuring And Mergern Acquisition: 71000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Retained Earnings: 12166000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Sale Of Investment: 39000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Selling General And Administration: 1055000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Share Issued: 4758000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Short Term Debt Issuance: 0.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Special Income Charges: -71000000.00
AVGO.TO cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 2092000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 87691000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: -38443000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: -5747285.29
AVGO.TO income_statement (quarterly, 2026-04-30) — Tax Provision: 820000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.08
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Total Assets: 179158000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 150346000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Total Debt: 64907000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 87691000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Total Expenses: 11328000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 91467000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 136945000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 72605000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Total Operating Income As Reported: 10788000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Total Tax Payable: 1217000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Total Unusual Items: -71000000.00
AVGO.TO income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: -71000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Tradeand Other Payables Non Current: 1662000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Work In Process: 1801000000.00
AVGO.TO balance_sheet (quarterly, 2026-04-30) — Working Capital: 23351000000.00
AVH.AX cash_flow (annual, 2021-06-30) — Common Stock Issuance: 69106000.00
AVH.AX cash_flow (annual, 2021-06-30) — Deferred Income Tax: 0.00
AVH.AX cash_flow (annual, 2021-06-30) — Deferred Tax: 0.00
AVH.AX cash_flow (annual, 2021-06-30) — Effect Of Exchange Rate Changes: 133000.00
AVH.AX cash_flow (annual, 2021-06-30) — Income Tax Paid Supplemental Data: 42000.00
AVH.AX cash_flow (annual, 2021-06-30) — Interest Paid Supplemental Data: 3000.00
AVH.AX balance_sheet (annual, 2021-06-30) — Investmentin Financial Assets: 0.00
AVH.AX balance_sheet (annual, 2021-06-30) — Investments And Advances: 0.00
AVH.AX cash_flow (annual, 2021-06-30) — Issuance Of Capital Stock: 69106000.00
AVH.AX cash_flow (annual, 2021-06-30) — Long Term Debt Payments: -11000.00
AVH.AX cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: 69106000.00
AVH.AX cash_flow (annual, 2021-06-30) — Net Issuance Payments Of Debt: -11000.00
AVH.AX cash_flow (annual, 2021-06-30) — Net Long Term Debt Issuance: -11000.00
AVH.AX cash_flow (annual, 2021-06-30) — Net Other Financing Charges: -5109000.00
AVH.AX balance_sheet (annual, 2021-06-30) — Non Current Deferred Assets: 613000.00
AVH.AX balance_sheet (annual, 2021-06-30) — Non Current Prepaid Assets: 148000.00
AVH.AX balance_sheet (annual, 2021-06-30) — Other Investments: 0.00
AVH.AX balance_sheet (annual, 2021-06-30) — Other Non Current Liabilities: 503000.00
AVH.AX income_statement (annual, 2021-06-30) — Other Operating Expenses: -2055000.00
AVH.AX balance_sheet (annual, 2021-06-30) — Prepaid Assets: 853000.00
AVH.AX cash_flow (annual, 2021-06-30) — Repayment Of Debt: -11000.00
AVH.AX balance_sheet (annual, 2021-06-30) — Restricted Cash: 201000.00
AVH.AX income_statement (annual, 2022-12-31) — +Operating Expense: 55885000.00
AVH.AX income_statement (annual, 2022-12-31) — +Total Revenue: 34421000.00
AVH.AX balance_sheet (annual, 2022-12-31) — Accounts Payable: 3002000.00
AVH.AX balance_sheet (annual, 2022-12-31) — Accounts Receivable: 3515000.00
AVH.AX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2152000.00
AVH.AX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 339825000.00
AVH.AX balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -24000000.00
AVH.AX cash_flow (annual, 2022-12-31) — Amortization Of Securities: -281000.00
AVH.AX cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 375000.00
AVH.AX balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 6930000.00
AVH.AX income_statement (annual, 2022-12-31) — Basic Average Shares: 125000900.00
AVH.AX income_statement (annual, 2022-12-31) — Basic EPS: -0.21
AVH.AX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 55712000.00
AVH.AX cash_flow (annual, 2022-12-31) — Capital Expenditure: -525000.00
AVH.AX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 918000.00
AVH.AX balance_sheet (annual, 2022-12-31) — Capital Stock: 3000.00
AVH.AX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 18164000.00
AVH.AX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 79342000.00
AVH.AX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 900000.00
AVH.AX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -19332000.00
AVH.AX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -19090000.00
AVH.AX cash_flow (annual, 2022-12-31) — Change In Account Payable: 282000.00
AVH.AX cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 1272000.00
AVH.AX cash_flow (annual, 2022-12-31) — Change In Inventory: -371000.00
AVH.AX cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -906000.00
AVH.AX cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -862000.00
AVH.AX cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 740000.00
AVH.AX cash_flow (annual, 2022-12-31) — Change In Payable: 282000.00
AVH.AX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1554000.00
AVH.AX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -366000.00
AVH.AX cash_flow (annual, 2022-12-31) — Change In Receivables: -985000.00
AVH.AX cash_flow (annual, 2022-12-31) — Change In Working Capital: -1196000.00
AVH.AX cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -395000.00
AVH.AX cash_flow (annual, 2022-12-31) — Changes In Cash: -37522000.00
AVH.AX balance_sheet (annual, 2022-12-31) — Common Stock: 3000.00
AVH.AX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 84740000.00
AVH.AX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
AVH.AX balance_sheet (annual, 2022-12-31) — Construction In Progress: 258000.00